TATA健康(01255)发布2024年度业绩，股东应占亏损6833.8万港元，同比扩大111.6%

Group 1 - TATA Health (01255) reported an annual performance for the year ending December 31, 2024, with revenue of HKD 124 million, a decrease of 40% year-on-year [1] - The company recorded a loss attributable to shareholders of HKD 68.338 million, which represents a year-on-year increase of 111.6% [1] - Basic loss per share was HKD 0.28 [1] Group 2 - The decline in revenue compared to the fiscal year 2023 was primarily due to a decrease in footwear business revenue [1] - The reduction in footwear business earnings was mainly attributed to ongoing economic uncertainty, which has weakened consumer sentiment, creating a challenging environment for the retail sector in Hong Kong [1]